Unicycive Therapeutics (UNCY) Cash & Equivalents (2021 - 2026)
Unicycive Therapeutics (UNCY) reported Cash & Equivalents of $44.19 million for Q2 2026, up 97.9% from $22.33 million a year earlier and up 18.2% from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Unicycive Therapeutics posted Cash & Equivalents of $29.2 million, up 11.7% from FY2024.
- Cash & Equivalents has a four-year compound annual growth rate of 15.2% (FY2021 to FY2025).
- By year, Cash & Equivalents came in at $26.14 million in FY2024 (+169.5%), $9.7 million in FY2023, $455,000 in FY2022 (-97.3%) and $16.58 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q1 2024.
- Year over year, Cash & Equivalents has now increased in each of the last four quarters, with growth averaging 52.4% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2024 (growth of 169.5%); the low point was Q4 2022 (a decline of 97.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $37.37 million (Q1 2026), $29.2 million (Q4 2025) and $42.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Unicycive Therapeutics | 104.44 Mn | -95.54 Mn | - | 44.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.19 Mn |
| Mar 31, 2026 | 37.37 Mn |
| Dec 31, 2025 | 29.20 Mn |
| Sep 30, 2025 | 42.70 Mn |
| Jun 30, 2025 | 22.33 Mn |
| Mar 31, 2025 | 19.77 Mn |
| Dec 31, 2024 | 26.14 Mn |
| Sep 30, 2024 | 32.35 Mn |
| Jun 30, 2024 | 41.78 Mn |
| Mar 31, 2024 | 48.93 Mn |
| Dec 31, 2023 | 9.70 Mn |
| Sep 30, 2023 | 14.35 Mn |
| Jun 30, 2023 | 18.82 Mn |
| Mar 31, 2023 | 24.33 Mn |
| Dec 31, 2022 | 455,000.00 |
| Sep 30, 2022 | 7.01 Mn |
| Jun 30, 2022 | 10.57 Mn |
| Mar 31, 2022 | 13.62 Mn |
| Dec 31, 2021 | 16.58 Mn |
| Sep 30, 2021 | 18.01 Mn |
API Access
Unicycive Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();